Patents Assigned to CNS THERAPEUTICS, INC.
  • NEURTURIN MOLECULES
    Publication number: 20110312883
    Abstract: Neurturin polypeptides which possess reduced heparin and heparan sulfate binding affinity but retain neurotrophic activity, nucleic acids which encode the neurturin variants and vectors and host cells which express the enhanced neurturin polypeptides. Use of the enhanced neurturin polypeptides, nucleic acids and host cells in the treatment or prevention of disease.
    Type: Application
    Filed: November 15, 2010
    Publication date: December 22, 2011
    Applicants: CNS THERAPEUTICS, INC.
    Inventors: Pia Runeberg-Roos, Maxim M. Bespalov, Richard Penn, Mart Saarma
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS AND RELATED DELIVERY SYSTEM
    Publication number: 20110269836
    Abstract: According to the subject invention, there is disclosed, a dosage and packaging configuration which includes the use of color-coded pre-filled syringes and vials to fill and refill infusion systems with existing and new dosage forms of intrathecal baclofen.
    Type: Application
    Filed: March 12, 2009
    Publication date: November 3, 2011
    Applicant: CNS Therapeutics, Inc.
    Inventors: John J. Foster, Thomas R. Prentice
  • INTRATHECAL BACLOFEN PHARMACEUTICAL DOSAGE FORMS WITH FEWER DEGRADATION PRODUCTS
    Publication number: 20100216887
    Abstract: The present invention relates generally to a sterile, particulate-free, stable intrathecal baclofen solution with less than 0.5% 4-(4-chlorophenyl)-2-pyrrolidone, a degradation product. These solutions are stable under a variety of storage conditions and for extended periods of time. Also disclosed are methods for preparing such compositions.
    Type: Application
    Filed: February 5, 2010
    Publication date: August 26, 2010
    Applicant: CNS THERAPEUTICS, INC.
    Inventors: John J. Foster, Angela S. Strantz